Study of brand-specific COVID-19 vaccine effectiveness against severe COVID-19 disease in Europe (former COVIDRIVE)

02/08/2021
25/09/2026
EU PAS number:
EUPAS42328
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

COVIDRIVE_TND-VE_MasterProtocol_v3.1

English (3.85 MB - PDF) View document
Updated protocol

Master Protocol Surveillance + VE_V3.0_02 Mar 2026.pdf

First published: 14/09/2026
English (830.1 KB - PDF) View document

COVID-19 Vaccine Effectiveness protocol v7.0_21 Feb 2025.pdf

First published: 23/04/2026
English (727.1 KB - PDF) View document

COVID-19 Vaccine Effectiveness protocol v7.0_21 Feb 2025.pdf

First published: 23/04/2026
English (727.1 KB - PDF) View document

COVID-19 Vaccine Effectiveness protocol v7.0_21 Feb 2025.pdf

First published: 16/09/2025
English (727.1 KB - PDF) View document

CVE_Master Protocol v6.0_21 Mar 2024.pdf

First published: 29/07/2024
English (883.8 KB - PDF) View document
Study results
Study report
Other information
Publications
Study publications
id.DRIVE publications list